Yung Hsiang Lin
Chief Executive Officer bij TCI CO., LTD.
Vermogen: 12 M $ op 31-03-2024
Profiel
Yung Hsiang Lin is currently the Chairman & General Manager at TCI Co., Ltd.
since 2017 and at TCI GENE, Inc. since 2014.
He is also a Director at TCI Firstek Corp.
and the President of Shanghai Biotech Co., Ltd.
Mr. Lin completed his undergraduate degree at National Chung Hsing University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TCI CO., LTD.
2.06% | 30-09-2022 | 2 441 405 ( 2.06% ) | 12 M $ | 31-03-2024 |
Actieve functies van Yung Hsiang Lin
| Bedrijven | Functie | Begin |
|---|---|---|
| TCI CO., LTD. | Chief Executive Officer | 01-04-2005 |
| TCI GENE INC. | Chief Executive Officer | 17-05-2012 |
| TCI Firstek Corp. | Director/Board Member | - |
Shanghai Biotech Co., Ltd.
 Shanghai Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of TCI Co., Ltd., Shanghai Biotech Co., Ltd. is a private company that manufactures pharmaceuticals and cosmetics. The company is based in Shanghai, China. | President | - |
Opleiding van Yung Hsiang Lin
| National Chung Hsing University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TCI CO., LTD. | Health Technology |
| TCI GENE INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
Shanghai Biotech Co., Ltd.
Shanghai Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of TCI Co., Ltd., Shanghai Biotech Co., Ltd. is a private company that manufactures pharmaceuticals and cosmetics. The company is based in Shanghai, China. | Health Technology |
| TCI Firstek Corp. |
